Chemoinformaics analysis of Lavandulyl propionate
| Molecular Weight | 210.317 | nRot | 7 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 3 |
| Exact Molecular Weight | 210.162 | nRing | 0 |
| Solubility: LogS | -3.746 | nHRing | 0 |
| Solubility: LogP | 3.881 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 37.9834 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.475 |
| Synth | 3.372 |
| Natural Product Likeliness | 1.15 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.481 |
| MDCK | 0.0000268 |
| BBB | 0.99 |
| PPB | 0.625036 |
| VDSS | 1.346 |
| FU | 0.412457 |
| CYP1A2-inh | 0.348 |
| CYP1A2-sub | 0.233 |
| CYP2c19-inh | 0.136 |
| CYP2c19-sub | 0.842 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.491 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.858 |
| CYP3a4-inh | 0.092 |
| CYP3a4-sub | 0.298 |
| CL | 11.222 |
| T12 | 0.59 |
| hERG | 0.015 |
| Ames | 0.014 |
| ROA | 0.021 |
| SkinSen | 0.241 |
| Carcinogencity | 0.676 |
| EI | 0.593 |
| Respiratory | 0.717 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.68655 |